https://www.selleckchem.com/pr....oducts/nvp-tnks656.h
MALAT1 as a lncRNA may be a tumor suppressor in patients with CML. According to our data, MALAT1 may have potential role as a molecular biomarker for the occurrence and development of CML resistance to dasatinib. MALAT1 as a lncRNA may be a tumor suppressor in patients with CML. According to our data, MALAT1 may have potential role as a molecular biomarker for the occurrence and development of CML resistance to dasatinib. Radiofrequency ablation (RFA) is the current gold standard for palliative care of non-small cell lung cancer (NS
Like
Comment
Share
